A Cytokine Boost for ICU Immunity: Restoring Neutrophil Function
A new study in *Thorax* reveals a promising therapeutic strategy for combating intensive care unit-acquired infections (ICU-AI). Researchers found that ex vivo application of interferon gamma (IFN-γ) can restore critical immune functions in dysfunctional neutrophils from critically ill patients. In an observational cohort study, neutrophils from 31 ICU patients with acquired dysfunction showed significant improvements in phagocytosis, bacterial killing, and superoxide generation after treatment. The study also identified the underlying mechanism, showing that the gamma isoform of phosphoinositide 3-kinase (PI3K-γ) and Fc gamma receptors are essential for this IFN-γ-mediated rescue of neutrophil effector functions.
Study Significance: For critical care specialists managing sepsis and ICU-acquired infections, this research points to a potential immunomodulatory therapy. It suggests that directly targeting neutrophil dysfunction could become a viable strategy to reduce infection susceptibility in vulnerable ICU patients. This mechanistic insight into PI3K-γ’s role offers a specific pathway for future drug development aimed at bolstering innate immunity during critical illness.
Source →Stay curious. Stay informed — with Science Briefing.
Always double check the original article for accuracy.
